Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-199,329
Closed -$6.7M 163
2022
Q1
$8.13M Buy
199,329
+13,657
+7% +$586K 2.13% 11
2021
Q4
$8.89M Sell
185,672
-574,037
-76% -$25.7M 2.31% 13
2021
Q3
$31.5M Buy
759,709
+167,959
+28% +$6.69M 9.04% 2
2021
Q2
$26.7M Buy
591,750
+6,639
+1% +$311K 7.86% 3
2021
Q1
$25.9M Buy
+585,111
New +$22.1M 6.84% 2

Other funds holding ADNT

Littlejohn & Co's ADNT Position: Q2 2022 in Review

Littlejohn & Co sold out of Adient (ADNT) in Q2 2022, closing a stake of 199,329 shares — an estimated $6.7M sold.

Littlejohn & Co first reported a position in ADNT in Q1 2021 and held it in 5 quarters. The position peaked at $31.5M in Q3 2021. 258 funds tracked by Wall St. Rank hold ADNT as of Q2 2022.

  • Littlejohn & Co reported no remaining Adient position as of Q2 2022 after selling out during the quarter.
  • Littlejohn & Co sold 199,329 Adient shares in Q2 2022, an estimated $6.7M.
  • Littlejohn & Co first reported a position in Adient in Q1 2021 and held it in 5 quarters.
  • Littlejohn & Co's Adient position peaked at $31.5M in Q3 2021.
  • 258 funds tracked by Wall St. Rank held Adient as of Q2 2022.

Based on Littlejohn & Co's 13F filing for Q2 2022, filed 8 Aug 2022.